Axsome Therapeutics AXSM Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's interest paid?
- Axsome Therapeutics (AXSM) reported interest paid of $2.93M in Q1 2026.
- How has Axsome Therapeutics's interest paid changed year-over-year?
- Axsome Therapeutics's interest paid decreased by 36.1% year-over-year, from $4.59M to $2.93M.
- What is the long-term trend for Axsome Therapeutics's interest paid?
- Over 4 years (2021 to 2025), Axsome Therapeutics's interest paid has grown at a 33.4% compound annual growth rate (CAGR), from $4.63M to $14.63M.
- What does interest paid mean?
- The amount of cash paid to lenders for interest on debt.
- How do you interpret interest paid?
- Higher interest paid relative to debt levels may indicate higher borrowing costs or increased leverage.
- How does interest paid compare across companies?
- Varies significantly based on capital structure and credit rating; common in capital-intensive sectors.